KALV vs REGN: Which Stock is Better?

Side-by-side comparison of Kalvista Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

KALV

Kalvista Pharmaceuticals Inc

$20.48

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricKALVREGNWinner
Market Cap$1.00B$78.87BREGN
P/E RatioN/A17.98REGN
EPS (TTM)$N/A$41.48REGN
Revenue Growth0.3%0.0%KALV
Gross Margin25.7%44.6%REGN

Analyze KALV

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is KALV or REGN a better investment?

Comparing KALV and REGN: Kalvista Pharmaceuticals Inc has a market cap of $1.00B while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between KALV and REGN?

KALV (Kalvista Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: KALV or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: KALV or REGN?

KALV has higher revenue growth at 0.3% vs 0.0% for REGN.

Which company is more profitable: KALV or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 25.7% for KALV.

Which is the larger company: KALV or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $1.00B for KALV.

Should I buy KALV or REGN in 2026?

Both KALV and REGN have investment merit. KALV trades at $20.48 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between KALV and REGN stock?

Key differences: Market Cap ($1.00B vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.3% vs 0.0%), Gross Margin (25.7% vs 44.6%).

Popular Stock Comparisons